Karyopharm Therapeutics competitors
Karyopharm Therapeutics's competitors include AVEO Pharmaceuticals, Nektar Therapeutics, Clovis Oncology and Infinity Pharmaceuticals
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. | |
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 1990 | Founding Date 2009 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Newton, US HQ München, DE | Locations Cambridge, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Boulder, US HQ | Locations Cambridge, US HQ |
Employees | Employees 108 | Employees 20 | Employees 468 | Employees 32718% increase | Employees 23 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 261.5 m | Valuation ($) 9.7 b | Valuation ($) 2.4 b | Valuation ($) 96.4 m |
Facebook likes | Facebook likes 126 | Facebook likes 445 | Facebook likes N/A | Facebook likes 22 | Facebook likes N/A |
Twitter followers | Twitter followers N/A | Twitter followers 650 | Twitter followers 629 | Twitter followers 495 | Twitter followers 1.8 k |
Financial | |||||
Net income | Net income ($109.6m) (FY, 2016) | Net income ($26.9m) (FY, 2016) | Net income ($96.7m) (FY, 2017) | Net income ($346.4m) (FY, 2017) | Net income ($41.8m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 248.7m | Total funding raised $ 138.2m | Total funding raised $ 45m | Total funding raised $ 357m | Total funding raised $ 178.5m |
For sources of this data, please see the company profileDownload Excel
View company profiles
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
468
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyClovis Oncology
HQ
Boulder, US
Employees
327↑ 18% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View companyInfinity Pharmaceuticals
HQ
Cambridge, US
Employees
23
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View company